Novel gene target shows promise for bladder cancer detection and treatment

NCI Cancer Center News

Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.

Click here to read full press release.

###

Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer?s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers? research results are often at the forefront of studies in the cancer field.

Source: http://feedproxy.google.com/~r/ncinewsreleases/~3/gwodfvHduIU/NovelGeneTargetBladderCancer

bruins Jimmy Hoffa Rick Rubin The Wolf of Wall Street marilyn monroe MAC Cosmetics The Voice Results